Related Experiment Video
Updated: Oct 11, 2025

03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.5K
[Development of Multiplex RT-PCR with Immobilized Primers for Identification of Infectious Human Pneumonia Pathogens]
S A Lapa1,2, R A Miftakhov1, E S Klochikhina1
1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.
Molekuliarnaia Biologiia
|November 27, 2021
Summary
A new multiplex real-time PCR system detects multiple pneumonia pathogens, including bacteria, influenza A, and SARS-CoV-2. This sensitive, contamination-resistant platform enhances infectious disease diagnostics.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Infectious Disease Research
Background:
- Pneumonia is a significant global health concern caused by diverse bacterial and viral pathogens.
- Accurate and rapid detection of these pathogens is crucial for effective treatment and control.
Purpose of the Study:
- To develop a prototype multiplex system for simultaneous detection of common pneumonia pathogens.
- To enhance diagnostic sensitivity and prevent cross-contamination in pathogen identification.
Main Methods:
- Multiplex solid-phase reverse transcription PCR (RT-PCR) assay development.
- Design of primers for six bacterial and two viral (Influenza A, SARS-CoV-2) pneumonia pathogens.
- Detection of fluorescent signals from incorporated labeled nucleotides after background signal reduction.
Main Results:
- Successful development of a prototype system capable of detecting multiple pneumonia pathogens.
- Achieved high sensitivity through reduced background noise and direct signal detection.
- Demonstrated suitability for simultaneous testing of numerous samples with minimized cross-contamination risk.
Conclusions:
- The developed multiplex RT-PCR platform offers a sensitive and reliable method for detecting various pneumonia pathogens.
- The system's open architecture allows for future expansion to include a wider range of infectious agents.
- This technology has the potential to significantly improve infectious pneumonia diagnostics.

